New Treatment for Painful Mouth Sores Due to Cancer TherapyMISSISSAUGA, Ontario, Nov. 20, 2023 BioSyent Inc. is pleased to announce that its subsidiary, BioSyent Pharma Inc., has commenced the.
Approximately 1.4 million Canadian women have PCOS, and this unique soft-gel capsule is approved to help them manage their symptomsMISSISSAUGA, Ontario, Aug. 08, 2023 BioSyent Inc. is pleased.
BioSyent Pharma to Introduce Gelclair® at AHNS 11th International Conference on Head and Neck Cancer itbusinessnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from itbusinessnet.com Daily Mail and Mail on Sunday newspapers.
BioSyent Pharma to Introduce Gelclair® at AHNS 11th globenewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globenewswire.com Daily Mail and Mail on Sunday newspapers.